Switch to: References

Add citations

You must login to add citations.
  1. A review of ethical frameworks for the disclosure of individual research results in population-based genetic and genomic research. [REVIEW]Isabelle Budin-Ljøsne - 2012 - Research Ethics 8 (1):25-42.
    Individual research results from population-based genetic and genomic research are traditionally not disclosed to research participants. Current practices of non-disclosure are, however, being challenged by an increasing number of scientists, ethicists and policy-makers who make arguments in favour of disclosing at least individual results of potential health or lifestyle significance to research participants. Simultaneously, research participants are expressing greater interest in accessing their results. This article first provides an overview of main arguments for and against the disclosure of individual research (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Informed consent and community engagement in open field research: lessons for gene drive science.Jerome Amir Singh - 2019 - BMC Medical Ethics 20 (1):54.
    The development of the CRISPR/Cas9 gene editing system has generated new possibilities for the use of gene drive constructs to reduce or suppress mosquito populations to levels that do not support disease transmission. Despite this prospect, social resistance to genetically modified organisms remains high. Gene drive open field research thus raises important questions regarding what is owed to those who may not consent to such research, or those could be affected by the proposed research, but whose consent is not solicited. (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Informed consent and community engagement in open field research: lessons for gene drive science.Jerome Amir Singh - 2019 - BMC Medical Ethics 20 (1):1-12.
    The development of the CRISPR/Cas9 gene editing system has generated new possibilities for the use of gene drive constructs to reduce or suppress mosquito populations to levels that do not support disease transmission. Despite this prospect, social resistance to genetically modified organisms remains high. Gene drive open field research thus raises important questions regarding what is owed to those who may not consent to such research, or those could be affected by the proposed research, but whose consent is not solicited. (...)
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Informed consent in cluster randomised trials: new and common ethical challenges.Sapfo Lignou - 2018 - Journal of Medical Ethics 44 (2):114-120.
    Cluster randomised trials are an increasingly important methodological tool in health research but they present challenges to the informed consent requirement. In the relatively limited literature on the ethics of cluster research there is not much clarity about the reasons for which seeking informed consent in cluster randomised trials may be morally challenging. In this paper, I distinguish between the cases where informed consent in cluster trials may be problematic due to the distinct features of ‘population-based’ interventions, which have not (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights from the HPV Vaccine in Canada.Ana Komparic, Maxwell J. Smith & Alison Thompson - 2016 - Public Health Ethics 9 (1):78-91.
    Health regulators must carefully monitor the real-world safety and effectiveness of marketed vaccines through post-market monitoring in order to protect the public’s health and promote those vaccines that best achieve public health goals. Yet, despite the fact that vaccines used in collective immunization programmes should be assessed in the context of a public health response, post-market effectiveness monitoring is often limited to assessing immunogenicity or limited programmatic features, rather than assessing effectiveness across populations. We argue that post-market monitoring ought to (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark